文献速递免疫规划

小鼠模型中接种疫苗对阴道和口腔黏膜HPV攻击的交叉中和保护

Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model.
PubMed 文献 · Vaccine · 2023-06-01

研究利用携带报告基因质粒的HPV假病毒(PsV)经阴道和口腔接种小鼠,评估实验性HPV预防性疫苗RG1-VLPs的被动转移与主动免疫保护效果。被动转移RG1-VLPs接种小鼠血清可使 naïve 受体小鼠获得针对HPV16的中和抗体及针对HPV39的交叉中和抗体;主动接种RG1-VLPs对阴道和口腔两个部位HPV16或HPV39 PsV攻击均提供保护。

要点

  • 被动转移RG1-VLPs接种小鼠血清使naïve小鼠获得HPV16中和及HPV39交叉中和抗体。
  • 主动接种RG1-VLPs对阴道和口腔两个部位HPV16或HPV39 PsV攻击均提供保护。
  • HPV PsV攻击模型适用于在阴道穹窿和口腔两个部位测试针对多种HPV型的疫苗保护。

核心结论

  • RG1-VLPs疫苗接种可在小鼠阴道和口腔黏膜对HPV16及HPV39 PsV攻击提供保护,支持HPV PsV攻击模型用于评估多型别、双部位疫苗保护。

研究设计与样本

  • 小鼠模型研究:利用携带报告基因质粒的HPV假病毒(PsV)经阴道和口腔接种,评估RG1-VLPs疫苗的被动转移和主动免疫保护。

主要发现

  • 被动转移RG1-VLPs接种小鼠血清后,naïve受体小鼠获得针对HPV16的中和抗体及针对HPV39的交叉中和抗体。
  • 主动接种RG1-VLPs对阴道和口腔两个部位HPV16或HPV39 PsV攻击均提供保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The species and tissue specificities of HPV (human papillomavirus) for human infection and disease complicates the process of prophylactic vaccine development in animal models. HPV pseudoviruses (PsV) that carry only a reporter plasmid have been utilized in vivo to demonstrate cell internalization in mouse mucosal epithelium. The current study sought to expand the application of this HPV PsV challenge model with both oral and vaginal inoculation and to demonstrate its utility for testing vaccine-mediated dual-site immune protection against several HPV PsV types. We observed that passive transfer of sera from mice vaccinated with the novel experimental HPV prophylactic vaccine RG1-VLPs (virus-like particles) conferred HPV16-neutralizing as well as cross-neutralizing Abs against HPV39 in naïve recipient mice. Moreover, active vaccination with RG1-VLPs also conferred protection to challenge with either HPV16 or HPV39 PsVs at both vaginal and oral sites of mucosal inoculation. These data support the use of the HPV PsV challenge model as suitable for testing against diverse HPV types at two sites of challenge (vaginal vault and oral cavity) associated with the origin of the most common HPV-associated cancers, cervical cancer and oropharyngeal cancer.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sanders C, Matthews RL, Esfahani SHZ, et al. Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model. Vaccine. 2023. PMID: 37270364. doi:10.1016/j.vaccine.2023.05.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。